Caricamento...
Comparison of twice-daily vs once-daily deferasirox dosing in a gerbil model of iron cardiomyopathy
OBJECTIVE: Despite the availability of deferoxamine chelation therapy for more than 20 years, iron cardiomyopathy remains the leading cause of death in thalassemia major patients. Effective chelation of cardiac iron is difficult; cardiac iron stores respond more slowly to chelation therapy and requi...
Salvato in:
Autori principali: | , , , , |
---|---|
Natura: | Artigo |
Lingua: | Inglês |
Pubblicazione: |
2007
|
Soggetti: | |
Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2892931/ https://ncbi.nlm.nih.gov/pubmed/17588475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exphem.2007.04.001 |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|